Youmagic Developer Vmay Medical Secures Over RMB 100 Million Series B Funding Led by Top-Tier Domestic Fund, with Keywin Capital as Exclusive Financial Advisor

Dec 17, 2024 07:59 CST Updated 08:00

WEMT

Provider of Minimally Invasive and Non-Invasive Energy Medicine Comprehensive Solutions

VCBeat has learned that recently, a monopolar radiofrequency skin treatment deviceYOUMAGIC^®WEMT, the R&D company, has completed a Series B financing round exceeding RMB 100 million, invested by a leading domestic fund.Kaicheng Capital served as the exclusive financial advisor. The related funds will be used to expandWEMT's Multi-Pipeline Layout in Energy Medicine and Medical Devices, accelerate the advancement of YOUMAGIC^®of core products such asProduction, expansion of sales channels, brand building, etc., for YOUMAGIC and WEMTR&D Innovation and Market ExpansionProvide robust financial support.

It is reported that the investors in this round chose to invest in WEMT, the developer of YOUMAGIC, primarily due to their confidence in YOUMAGIC.^®Leveraging the innovative technological advantages and market potential of high-energy monopolar radiofrequency technology, along with WEMT’s profound background and strength in the field of energy medicine, both parties aim to join forces to drive technological advancements in energy medicine and accelerate the adoption of high-end domestically produced alternatives in the healthcare industry.

NMPA Class III Certification Approval Highlights Innovation Strength; Capital Support Accelerates YOUMAGIC’s Commercial Launch

This timeSeries B Financing, AtYOUMAGIC and its developer, WEMTCritical Period for Strategic Development, which also coincides withYOUMAGIC^®A Favorable Opportunity for Successful Approval of the NMPA Class III Medical Device Registration Certificate. The approval of this registration certificate fully demonstrates the safety, reliability, clinical efficacy, and rigorous testing of WEMT’s product technology, markingYOUMAGIC^®"Having established technological barriers and competitive advantages, we have fully embarked on our commercialization journey."

For a long time, the domestic market for high-end photoelectric medical devices has seen extensive demand, but the industry’s level of technological self-sufficiency remains low, resulting in a reliance on imports. YOUMAGIC^®The approval of the high-energy monopolar radiofrequency skin treatment device has become a turning point for the industry's standardized and healthy development, ushering inTechnological Independence and High-End Domestic Substitutiona significant opportunity, while also providing forCapital Influx Opens a Window of Opportunity.

Throughout, strong commercial demand, high technical entry barriers, and differentiated product experiences have been key to WEMT, the developer of YOUMAGIC, standing out in the market and attracting investment. Prior to this round of financing, WEMT hadHaving garnered repeated favor from the capital market, the company has secured cumulative financial investments amounting to hundreds of millions of yuan across multiple rounds from prominent domestic investment institutions, as well as strategic investments from Proya, Botanee Group, Trautec Group, and Jointown Pharmaceutical Group.

With the increased investment from major investors in this round, the development of YOUMAGIC and WEMT will accelerate significantly. The funding will robustly support WEMT’s continuous R&D innovation, expansion of its product pipeline, and strengthening of its industrial layout, thereby empowering YOUMAGIC^®expansion of core products such asLarge Market Share, Accelerated CommercializationLay a Solid Foundation.

Strengthen R&D and Market Expansion to Accelerate High-End Domestic Substitution, Leading the Industry Toward “New”

Currently, “high-end domestic substitution” is not only a response to market demand but also an inevitable trend driven by national policy support and industrial development. YOUMAGIC and its R&D company, WEMT, stated that they will continue to focus on technological innovation and commercialization in the fields of energy medicine and high-end medical devices. They remain committed to gaining deep insights into users’ diverse and personalized needs, developing products with high entry barriers, filling gaps in existing medical procedures, and advancing the substitution of imported high-end devices with domestically produced alternatives.

Driven by technological advancements and policies such as “developing new quality productive forces” and “innovation-driven development,” with theYOUMAGIC^®Approval of the NMPA Class III Medical Device Certificate,WEMT’s innovative practices, along with its experience and accumulated expertise in technology transfer and clinical trials, are expected toTo provide effective standard-based evidence and theoretical support for industry development, thereby driving standardization and enhancing the overall R&D capabilities of the sector.enhancement. In the future, WEMT will leverage innovative practicesAccumulate new momentum for development, drive the industry to embrace “new” changes, and continuously inject fresh vitality into China’s industrial system for the commercialization of scientific and technological achievements.

Investors in this round stated“YOUMAGIC R&D CompanyWEMTFocused on the field of energy medicine, with high-performance radiofrequency (RF) energy systems as its technological core, it possesses decades of R&D experience in the fields of energy sources and sensors.Deep Technological Foundation, Diversified Product Pipeline. The core team possesses extensive scientific research experience and a profound industrial background, enabling the company's sustainedInnovation Provides Solid Assurance, with extensive experience in clinical research. WeHighly BullishYOUMAGIC^®the commercial potential of high-energy monopolar radiofrequency skin treatment devices, and we are confident that YOUMAGIC and WEMT will create greater value for consumers through their outstanding product innovation capabilities.”

Kaicheng CapitalIndicates“The integration of medicine and engineering is the fundamental driving force behind the continuous advancement of the innovative medical device industry. We have consistently focused on teams that possess both technological prowess and clinical expertise, and YOUMAGIC along with its R&D company, WEMT, are true pioneers in this field. We hold a highly favorable view of WEMT’s management team for their keen market insight, solid technical strength, and exceptional fundraising capabilities. Companies that gain joint recognition from various types of institutional investors and industry players are few and far between. The participation of these renowned leading institutions, leveraging their extensive resource networks and profound industry understanding, will undoubtedly propel WEMT to new heights.”